240 related articles for article (PubMed ID: 23469184)
1. Genome-wide association analysis identifies a mutation in the thiamine transporter 2 (SLC19A3) gene associated with Alaskan Husky encephalopathy.
Vernau KM; Runstadler JA; Brown EA; Cameron JM; Huson HJ; Higgins RJ; Ackerley C; Sturges BK; Dickinson PJ; Puschner B; Giulivi C; Shelton GD; Robinson BH; DiMauro S; Bollen AW; Bannasch DL
PLoS One; 2013; 8(3):e57195. PubMed ID: 23469184
[TBL] [Abstract][Full Text] [Related]
2. Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome.
Gerards M; Kamps R; van Oevelen J; Boesten I; Jongen E; de Koning B; Scholte HR; de Angst I; Schoonderwoerd K; Sefiani A; Ratbi I; Coppieters W; Karim L; de Coo R; van den Bosch B; Smeets H
Brain; 2013 Mar; 136(Pt 3):882-90. PubMed ID: 23423671
[TBL] [Abstract][Full Text] [Related]
3. Thiamine Deficiency-Mediated Brain Mitochondrial Pathology in Alaskan Huskies with Mutation in SLC19A3.1.
Vernau K; Napoli E; Wong S; Ross-Inta C; Cameron J; Bannasch D; Bollen A; Dickinson P; Giulivi C
Brain Pathol; 2015 Jul; 25(4):441-53. PubMed ID: 25117056
[TBL] [Abstract][Full Text] [Related]
4.
Drögemüller M; Letko A; Matiasek K; Jagannathan V; Corlazzoli D; Rosati M; Jurina K; Medl S; Gödde T; Rupp S; Fischer A; Luján Feliu-Pascual A; Drögemüller C
Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33081289
[TBL] [Abstract][Full Text] [Related]
5. Free-thiamine is a potential biomarker of thiamine transporter-2 deficiency: a treatable cause of Leigh syndrome.
Ortigoza-Escobar JD; Molero-Luis M; Arias A; Oyarzabal A; Darín N; Serrano M; Garcia-Cazorla A; Tondo M; Hernández M; Garcia-Villoria J; Casado M; Gort L; Mayr JA; Rodríguez-Pombo P; Ribes A; Artuch R; Pérez-Dueñas B
Brain; 2016 Jan; 139(Pt 1):31-8. PubMed ID: 26657515
[TBL] [Abstract][Full Text] [Related]
6. Leigh-like subacute necrotising encephalopathy in Yorkshire Terriers: neuropathological characterisation, respiratory chain activities and mitochondrial DNA.
Baiker K; Hofmann S; Fischer A; Gödde T; Medl S; Schmahl W; Bauer MF; Matiasek K
Acta Neuropathol; 2009 Nov; 118(5):697-709. PubMed ID: 19466433
[TBL] [Abstract][Full Text] [Related]
7. Vitamin B1 deficiency leads to high oxidative stress and mtDNA depletion caused by SLC19A3 mutation in consanguineous family with Leigh syndrome.
Felhi R; Sfaihi L; Charif M; Frikha F; Aoiadni N; Kamoun T; Lenaers G; Fakhfakh F
Metab Brain Dis; 2023 Oct; 38(7):2489-2497. PubMed ID: 37642897
[TBL] [Abstract][Full Text] [Related]
8. Exome sequencing reveals mutated SLC19A3 in patients with an early-infantile, lethal encephalopathy.
Kevelam SH; Bugiani M; Salomons GS; Feigenbaum A; Blaser S; Prasad C; Häberle J; Baric I; Bakker IM; Postma NL; Kanhai WA; Wolf NI; Abbink TE; Waisfisz Q; Heutink P; van der Knaap MS
Brain; 2013 May; 136(Pt 5):1534-43. PubMed ID: 23482991
[TBL] [Abstract][Full Text] [Related]
9. Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy.
Flønes I; Sztromwasser P; Haugarvoll K; Dölle C; Lykouri M; Schwarzlmüller T; Jonassen I; Miletic H; Johansson S; Knappskog PM; Bindoff LA; Tzoulis C
PLoS One; 2016; 11(2):e0149055. PubMed ID: 26863430
[TBL] [Abstract][Full Text] [Related]
10. Eleven novel mutations and clinical characteristics in seven Chinese patients with thiamine metabolism dysfunction syndrome.
Li D; Song J; Li X; Liu Y; Dong H; Kang L; Liu Y; Zhang Y; Jin Y; Guan H; Zhou C; Yang Y
Eur J Med Genet; 2020 Oct; 63(10):104003. PubMed ID: 32679198
[TBL] [Abstract][Full Text] [Related]
11. Genetic defects of thiamine transport and metabolism: A review of clinical phenotypes, genetics, and functional studies.
Marcé-Grau A; Martí-Sánchez L; Baide-Mairena H; Ortigoza-Escobar JD; Pérez-Dueñas B
J Inherit Metab Dis; 2019 Jul; 42(4):581-597. PubMed ID: 31095747
[TBL] [Abstract][Full Text] [Related]
12. Thiamine transporter-2 deficiency: outcome and treatment monitoring.
Ortigoza-Escobar JD; Serrano M; Molero M; Oyarzabal A; Rebollo M; Muchart J; Artuch R; Rodríguez-Pombo P; Pérez-Dueñas B
Orphanet J Rare Dis; 2014 Jun; 9():92. PubMed ID: 24957181
[TBL] [Abstract][Full Text] [Related]
13. SLC19A3 encodes a second thiamine transporter ThTr2.
Rajgopal A; Edmondnson A; Goldman ID; Zhao R
Biochim Biophys Acta; 2001 Nov; 1537(3):175-8. PubMed ID: 11731220
[TBL] [Abstract][Full Text] [Related]
14. Stress-induced upregulation of SLC19A3 is impaired in biotin-thiamine-responsive basal ganglia disease.
Schänzer A; Döring B; Ondrouschek M; Goos S; Garvalov BK; Geyer J; Acker T; Neubauer B; Hahn A
Brain Pathol; 2014 Apr; 24(3):270-9. PubMed ID: 24372704
[TBL] [Abstract][Full Text] [Related]
15. A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations.
Yamada K; Miura K; Hara K; Suzuki M; Nakanishi K; Kumagai T; Ishihara N; Yamada Y; Kuwano R; Tsuji S; Wakamatsu N
BMC Med Genet; 2010 Dec; 11():171. PubMed ID: 21176162
[TBL] [Abstract][Full Text] [Related]
16. pH-dependent pyridoxine transport by SLC19A2 and SLC19A3: Implications for absorption in acidic microclimates.
Yamashiro T; Yasujima T; Said HM; Yuasa H
J Biol Chem; 2020 Dec; 295(50):16998-17008. PubMed ID: 33008889
[TBL] [Abstract][Full Text] [Related]
17. Compound heterozygous
Whitford W; Hawkins I; Glamuzina E; Wilson F; Marshall A; Ashton F; Love DR; Taylor J; Hill R; Lehnert K; Snell RG; Jacobsen JC
Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 28696212
[TBL] [Abstract][Full Text] [Related]
18. Biotin-thiamine responsive basal ganglia disease: Identification of a pyruvate peak on brain spectroscopy, novel mutation in SLC19A3, and calculation of prevalence based on allele frequencies from aggregated next-generation sequencing data.
Ferreira CR; Whitehead MT; Leon E
Am J Med Genet A; 2017 Jun; 173(6):1502-1513. PubMed ID: 28402605
[TBL] [Abstract][Full Text] [Related]
19. Role of HIF-1α in the hypoxia inducible expression of the thiamine transporter, SLC19A3.
Zera K; Sweet R; Zastre J
Gene; 2016 Dec; 595(2):212-220. PubMed ID: 27743994
[TBL] [Abstract][Full Text] [Related]
20. Neuropathological characteristics of the brain in two patients with SLC19A3 mutations related to the biotin-thiamine-responsive basal ganglia disease.
Pronicki M; Piekutowska-Abramczuk D; Jurkiewicz E; Rokicki D; Ciara E; Trubicka J; Iwanicka-Pronicka K; Pajdowska M; Migdał M; Grajkowska WA
Folia Neuropathol; 2017; 55(2):146-153. PubMed ID: 28677371
[No Abstract] [Full Text] [Related]
[Next] [New Search]
